Phase 1b investigation of the MEK inhibitor binimetinib in patients with advanced or metastatic biliary tract cancer.
Invest New Drugs
; 36(6): 1037-1043, 2018 12.
Article
in En
| MEDLINE
| ID: mdl-29785570
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Benzimidazoles
/
Biliary Tract Neoplasms
/
Protein Kinase Inhibitors
Type of study:
Clinical_trials
/
Observational_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Invest New Drugs
Year:
2018
Type:
Article
Affiliation country:
United States